These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 18330481

  • 1. Synthetic liver X receptor agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in apolipoprotein E knockout mice.
    Dai X, Ou X, Hao X, Cao D, Tang Y, Hu Y, Li X, Tang C.
    Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):261-8. PubMed ID: 18330481
    [Abstract] [Full Text] [Related]

  • 2. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
    Ou X, Dai X, Long Z, Tang Y, Cao D, Hao X, Hu Y, Li X, Tang C.
    Sci China C Life Sci; 2008 May; 51(5):418-29. PubMed ID: 18785587
    [Abstract] [Full Text] [Related]

  • 3. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY, Ou X, Hao XR, Cao DL, Tang YL, Hu YW, Li XX, Tang CK.
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [Abstract] [Full Text] [Related]

  • 4. Effect of T0901317 on hepatic proinflammatory gene expression in apoE-/- mice fed a high-fat/high-cholesterol diet.
    Dai X, Ou X, Hao X, Cao D, Tang Y, Hu Y, Li X, Tang C.
    Inflammation; 2007 Aug; 30(3-4):105-17. PubMed ID: 17516158
    [Abstract] [Full Text] [Related]

  • 5. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W, Zhang T, Cheng J, Zhou X, Qu X, Hu H.
    Pharmacology; 2010 Aug; 86(5-6):306-12. PubMed ID: 21071998
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
    Wang SH, Yu TY, Tsai FC, Weston CJ, Lin MS, Hung CS, Kao HL, Li YI, Solé M, Unzeta M, Chen YL, Chuang LM, Li HY.
    Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
    Wang SH, Yu TY, Hung CS, Yang CY, Lin MS, Su CY, Chen YL, Kao HL, Chuang LM, Tsai FC, Li HY.
    Sci Rep; 2018 Jun 18; 8(1):9249. PubMed ID: 29915377
    [Abstract] [Full Text] [Related]

  • 8. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
    Verschuren L, de Vries-van der Weij J, Zadelaar S, Kleemann R, Kooistra T.
    J Lipid Res; 2009 Feb 18; 50(2):301-11. PubMed ID: 18757914
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells.
    Peng Y, Wang J, Zhang M, Niu P, Yang M, Yang Y, Zhao Y.
    PLoS One; 2016 Feb 18; 11(4):e0152758. PubMed ID: 27043821
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y, Duan Y, Yang X, Sun L, Liu M, Wang Q, Ma X, Zhang W, Li X, Hu W, Miao RQ, Xiang R, Hajjar DP, Han J.
    Arterioscler Thromb Vasc Biol; 2015 Apr 18; 35(4):948-59. PubMed ID: 25810299
    [Abstract] [Full Text] [Related]

  • 11. Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.
    van der Stoep M, Li Z, Calpe-Berdiel L, van der Sluis RJ, Saleh P, McKinnon HJ, Smit MJ, Korporaal SJ, Van Berkel TJ, Van Eck M, Hoekstra M.
    Biochem Pharmacol; 2013 Dec 01; 86(11):1594-602. PubMed ID: 24095721
    [Abstract] [Full Text] [Related]

  • 12. Effects of semicarbazide-sensitive amine oxidase inhibitors on morphology of aorta and kidney in diabetic rats.
    Li C, Wang Z, Li X, Chen J.
    BMC Endocr Disord; 2019 Jun 10; 19(1):59. PubMed ID: 31182088
    [Abstract] [Full Text] [Related]

  • 13. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes.
    Liang Y, Lin S, Beyer TP, Zhang Y, Wu X, Bales KR, DeMattos RB, May PC, Li SD, Jiang XC, Eacho PI, Cao G, Paul SM.
    J Neurochem; 2004 Feb 10; 88(3):623-34. PubMed ID: 14720212
    [Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM, Wang EY, Miller A, Podar EM, Scheyhing K, Huang L, Kessler C, Gao H, Ton-Nu HT, Macdonald MT, Jones DS, Linnik MD.
    J Pharmacol Exp Ther; 2008 Feb 10; 324(2):867-75. PubMed ID: 17993604
    [Abstract] [Full Text] [Related]

  • 15. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317.
    Peng D, Hiipakka RA, Reardon CA, Getz GS, Liao S.
    Atherosclerosis; 2009 Mar 10; 203(1):59-66. PubMed ID: 18639878
    [Abstract] [Full Text] [Related]

  • 16. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
    Zhang X, Zhu Z, Luo G, Zheng L, Nilsson-Ehle P, Xu N.
    Biochem Biophys Res Commun; 2008 Jun 20; 371(1):114-7. PubMed ID: 18413148
    [Abstract] [Full Text] [Related]

  • 17. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
    Carpéné C, Bizou M, Tréguer K, Hasnaoui M, Grès S.
    J Physiol Biochem; 2015 Sep 20; 71(3):487-96. PubMed ID: 25572340
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of semicarbazide-sensitive amine oxidase induces the phenotypic switch of smooth muscle cells and aggravates the development of atherosclerotic lesions.
    Zhang M, Liu L, Zhi F, Niu P, Yang M, Zhu X, Diao Y, Li Y, Wang J, Zhao Y.
    Atherosclerosis; 2016 Jun 20; 249():76-82. PubMed ID: 27065245
    [Abstract] [Full Text] [Related]

  • 19. Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice.
    Liu Y, Yan C, Wang Y, Nakagawa Y, Nerio N, Anghel A, Lutfy K, Friedman TC.
    Endocrinology; 2006 Nov 20; 147(11):5061-8. PubMed ID: 16873540
    [Abstract] [Full Text] [Related]

  • 20. Elevated semicarbazide-sensitive amine oxidase (SSAO) activity in lung with ischemia-reperfusion injury: protective effect of ischemic preconditioning plus SSAO inhibition.
    Ucar G, Topaloglu E, Burak Kandilci H, Gumusel B.
    Life Sci; 2005 Dec 12; 78(4):421-7. PubMed ID: 16111719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.